
|Articles|May 20, 2015
- Genitourinary (Issue 2)
- Issue 2
Trends in PSA Utilization in Primary Care Physicians
Author(s)Ryan Werntz, MD
Ryan Werntz, MD, urologist, Oregon Health and Science University, discusses a study which examined trends in prostate-specific antigen (PSA) utilization in primary care physicians.
Advertisement
Ryan Werntz, MD, urologist, Oregon Health and Science University, discusses a study which examined trends in prostate-specific antigen (PSA) utilization in primary care physicians.
<<<
Articles in this issue
over 10 years ago
Use of ARN-509 in Prostate Cancerover 10 years ago
Abiraterone Plus Low-Dose Prednisone Lowers PSA in High-Risk M0 CRPCover 10 years ago
Study Illuminates Role of AR-V7 in Carcinogenesisover 10 years ago
PSA Screening Drops 50% Following USPSTF Recommendationover 10 years ago
Urine-Based Diagnostic Effectively Identifies Prostate Cancerover 10 years ago
AR-V7 as a Biomarker in CRPCAdvertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
3
JANX007 Shows Promising Efficacy, Safety in Phase 1 Trial Update
4
LP-184 Demonstrates Favorable Efficacy and Safety in Advanced Solid Tumors
5








































